Latest Biotech News

CSL has invested $117 million upfront in Dutch biotech VarmX, obtaining an option to acquire its Phase 3-ready drug candidate poised to reverse anticoagulant effects, such as those from Eliquis,...

South Korea's Ministry of Food and Drug Safety announced plans to raise application fees for biosimilar drug approvals significantly while expediting review timelines beginning next year. This...

Bionano Genomics has priced a public offering of 5 million shares at $2.00 each, raising approximately $10 million before expenses, with warrants potentially bringing an additional $20 million if...

Enhanced Genomics, a UK-based drug discovery firm utilizing a 3D multiomics platform called GenLink, raised an extended Series A funding round totaling $19 million. The capital will support...

Parse Biosciences launched the Evercode WT Penta and Penta 384 platforms, enabling whole transcriptome single-cell RNA sequencing at unprecedented scales—up to five million cells and 384 samples...

Amid a challenging funding environment post-pandemic, multiple Boston-area biotech startups have shuttered or downsized, including NextRNA Therapeutics. Despite promising science and prior...

Novartis has cemented a second collaboration with Monte Rosa Therapeutics, making a $120 million upfront payment for exclusive rights to an undisclosed protein degrader target and options on two...

aTyr Pharma announced that its lead candidate, efzofitimod, failed to meet the primary endpoint in a Phase 3 trial for pulmonary sarcoidosis, showing no statistically significant steroid dose...

Bionano Genomics has priced a public offering of 5 million common stock shares at $2.00 each, aiming to raise $10 million before expenses, with concurrent offerings of up to 5 million Series E and...

Enhanced Genomics, a Cambridge, UK-based drug discovery startup spun out from the Babraham Institute, has closed additional funding to increase its Series A round to $19 million. The firm is...

The US Department of Commerce's Bureau of Industry and Security added 32 new entities to its Entity List, notably including three Chinese biotechnology companies: Beijing Tianyi Huiyuan...

A novel artificial intelligence-based deep learning algorithm has demonstrated superior accuracy in stratifying malignancy risk of lung nodules, according to recent findings published in...

Researchers using multicolor fate mapping techniques in mouse models have elucidated the intricate polyclonal proliferation and heterogeneity of microglia following ischemic stroke. The study...

A recent study demonstrated that stem cell transplantation enhances brain cell regeneration and improves functional recovery following ischemic stroke in mouse models. The findings underscore the...

Privately held Areteia Therapeutics announced that dexpramipexole, an oral twice-daily drug candidate, met its primary endpoint by improving lung function in a placebo-controlled Phase 3 study...

Flagship Pioneering-backed startup Lila Sciences secured $235 million in Series A funding to develop 'scientific superintelligence' by integrating artificial intelligence into laboratory research...

Novartis has expanded its partnership with Monte Rosa Therapeutics by acquiring exclusive rights to a new molecular glue degrader candidate for immune diseases, along with options for two...

Biotech company ATyr Pharma announced that its lead drug candidate, efzofitimod, did not meet the primary endpoint in a Phase 3 trial for pulmonary sarcoidosis, an inflammatory lung disease. The...

Novo Nordisk disclosed plans to reduce its global workforce by 11.5%, equating to approximately 9,000 layoffs, as part of a company restructuring aimed at enhancing commercial execution in...

Researchers at the Berlin Institute for Medical Systems Biology have developed Flexynesis, a deep learning framework designed to integrate diverse multi-omics datasets, including genomic,...